NCT02829619

Brief Summary

Meal times differ from culture to culture. These differences may influence energy regulation and, consequently, body weight. Current studies support the notion that not only "what" but also "when" the investigators eat may have a significant role in obesity treatment. Recently, it has been shown that eating the main meal of the day, lunch in Spain, late in the day is predictive of difficulty in weight loss and decreased insulin sensitivity. This project aims to study in a Mediterranean population the potential influence of genetics and food timing on obesity, metabolic syndrome and weight loss.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,788

participants targeted

Target at P75+ for all trials

Timeline
74mo left

Started Jan 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Jan 2008Jun 2032

Study Start

First participant enrolled

January 1, 2008

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

June 10, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 12, 2016

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2032

Last Updated

May 6, 2026

Status Verified

May 1, 2024

Enrollment Period

19.4 years

First QC Date

June 10, 2016

Last Update Submit

April 29, 2026

Conditions

Keywords

ObesityNutrigeneticsFood TimingWeight loss

Outcome Measures

Primary Outcomes (2)

  • Total weight loss

    Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg, at the same time each day.

    weekly, during the 28 weeks of treatment

  • Long term weight loss maintenance

    Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg.

    once at least one year after ending the treatment

Secondary Outcomes (18)

  • Food timing

    at baseline

  • Sleep timing

    at baseline

  • Siesta timing questionnaire

    at baseline

  • Individual chronotype questionnaire

    at baseline

  • Food habits questionnaire

    at baseline

  • +13 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All participants are voluntarily attending five weight loss clinics in Spain for dietetic and behavioral treatment based upon the principles of a Mediterranean diet . All participants are from the Spanish city of Murcia, located on the Southeast coast of the Mediterranean Sea.

You may qualify if:

  • Body Mass Index: \>25 kg/m2
  • Age: \>18 years of age
  • Caucasian

You may not qualify if:

  • Receiving treatment with thermogenic, lipogenic, or contraceptive drugs
  • Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis
  • bulimia diagnosis, prone to binge eating
  • undergoing treatment with anxiolytic or antidepressant drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Murcia

Murcia, Murcia, 30100, Spain

RECRUITING

Related Publications (34)

  • Garaulet M, Vera B, Bonnet-Rubio G, Gomez-Abellan P, Lee YC, Ordovas JM. Lunch eating predicts weight-loss effectiveness in carriers of the common allele at PERILIPIN1: the ONTIME (Obesity, Nutrigenetics, Timing, Mediterranean) study. Am J Clin Nutr. 2016 Oct;104(4):1160-1166. doi: 10.3945/ajcn.116.134528. Epub 2016 Sep 14.

    PMID: 27629052BACKGROUND
  • Gomez-Santos C, Saura CB, Lucas JA, Castell P, Madrid JA, Garaulet M. Menopause status is associated with circadian- and sleep-related alterations. Menopause. 2016 Jun;23(6):682-90. doi: 10.1097/GME.0000000000000612.

    PMID: 27093617BACKGROUND
  • Corbalan-Tutau MD, Gomez-Abellan P, Madrid JA, Canteras M, Ordovas JM, Garaulet M. Toward a chronobiological characterization of obesity and metabolic syndrome in clinical practice. Clin Nutr. 2015 Jun;34(3):477-83. doi: 10.1016/j.clnu.2014.05.007. Epub 2014 May 28.

    PMID: 24953771BACKGROUND
  • Lopez-Guimera G, Dashti HS, Smith CE, Sanchez-Carracedo D, Ordovas JM, Garaulet M. CLOCK 3111 T/C SNP interacts with emotional eating behavior for weight-loss in a Mediterranean population. PLoS One. 2014 Jun 6;9(6):e99152. doi: 10.1371/journal.pone.0099152. eCollection 2014.

    PMID: 24905098BACKGROUND
  • Dashti HS, Smith CE, Lee YC, Parnell LD, Lai CQ, Arnett DK, Ordovas JM, Garaulet M. CRY1 circadian gene variant interacts with carbohydrate intake for insulin resistance in two independent populations: Mediterranean and North American. Chronobiol Int. 2014 Jun;31(5):660-7. doi: 10.3109/07420528.2014.886587. Epub 2014 Feb 18.

    PMID: 24548145BACKGROUND
  • Bandin C, Martinez-Nicolas A, Ordovas JM, Madrid JA, Garaulet M. Circadian rhythmicity as a predictor of weight-loss effectiveness. Int J Obes (Lond). 2014 Aug;38(8):1083-8. doi: 10.1038/ijo.2013.211. Epub 2013 Nov 15.

    PMID: 24232497BACKGROUND
  • Garaulet M, Smith CE, Gomez-Abellan P, Ordovas-Montanes M, Lee YC, Parnell LD, Arnett DK, Ordovas JM. REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American. Mol Nutr Food Res. 2014 Apr;58(4):821-9. doi: 10.1002/mnfr.201300361. Epub 2013 Oct 31.

    PMID: 24173768BACKGROUND
  • Garaulet M, Gomez-Abellan P. Chronobiology and obesity. Nutr Hosp. 2013 Sep;28 Suppl 5:114-20. doi: 10.3305/nh.2013.28.sup5.6926.

    PMID: 24010751BACKGROUND
  • Morales-Falo EM, Sanchez-Moreno C, Esteban A, Alburquerque JJ, Garaulet M. [Quality of the diet "before and during" a weight loss treatment based on Mediterranean Diet; behavioural therapy and nutritional education]. Nutr Hosp. 2013 Jul-Aug;28(4):980-7. doi: 10.3305/nh.2013.28.4.6665. Spanish.

    PMID: 23889612BACKGROUND
  • Garaulet M, Gomez-Abellan P, Alburquerque-Bejar JJ, Lee YC, Ordovas JM, Scheer FA. Timing of food intake predicts weight loss effectiveness. Int J Obes (Lond). 2013 Apr;37(4):604-11. doi: 10.1038/ijo.2012.229. Epub 2013 Jan 29.

    PMID: 23357955BACKGROUND
  • Bandin C, Martinez-Nicolas A, Ordovas JM, Ros Lucas JA, Castell P, Silvente T, Madrid JA, Garaulet M. Differences in circadian rhythmicity in CLOCK 3111T/C genetic variants in moderate obese women as assessed by thermometry, actimetry and body position. Int J Obes (Lond). 2013 Aug;37(8):1044-50. doi: 10.1038/ijo.2012.180. Epub 2012 Nov 20.

    PMID: 23183326BACKGROUND
  • Milagro FI, Gomez-Abellan P, Campion J, Martinez JA, Ordovas JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 2012 Nov;29(9):1180-94. doi: 10.3109/07420528.2012.719967. Epub 2012 Sep 24.

    PMID: 23003921BACKGROUND
  • Garaulet M, Canteras M, Morales E, Lopez-Guimera G, Sanchez-Carracedo D, Corbalan-Tutau MD. Validation of a questionnaire on emotional eating for use in cases of obesity: the Emotional Eater Questionnaire (EEQ). Nutr Hosp. 2012 Mar-Apr;27(2):645-51. doi: 10.1590/S0212-16112012000200043.

    PMID: 22732995BACKGROUND
  • Corbalan-Tutau D, Madrid JA, Nicolas F, Garaulet M. Daily profile in two circadian markers "melatonin and cortisol" and associations with metabolic syndrome components. Physiol Behav. 2014 Jan 17;123:231-5. doi: 10.1016/j.physbeh.2012.06.005. Epub 2012 Jun 15.

    PMID: 22705307BACKGROUND
  • Corbalan-Tutau MD, Madrid JA, Garaulet M. Timing and duration of sleep and meals in obese and normal weight women. Association with increase blood pressure. Appetite. 2012 Aug;59(1):9-16. doi: 10.1016/j.appet.2012.03.015. Epub 2012 Mar 23.

    PMID: 22450522BACKGROUND
  • Garaulet M, Esteban Tardido A, Lee YC, Smith CE, Parnell LD, Ordovas JM. SIRT1 and CLOCK 3111T> C combined genotype is associated with evening preference and weight loss resistance in a behavioral therapy treatment for obesity. Int J Obes (Lond). 2012 Nov;36(11):1436-41. doi: 10.1038/ijo.2011.270. Epub 2012 Feb 7.

    PMID: 22310473BACKGROUND
  • Garaulet M, Smith CE, Hernandez-Gonzalez T, Lee YC, Ordovas JM. PPARgamma Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet. Mol Nutr Food Res. 2011 Dec;55(12):1771-9. doi: 10.1002/mnfr.201100437. Epub 2011 Nov 21.

    PMID: 22102511BACKGROUND
  • Corbalan-Tutau MD, Madrid JA, Ordovas JM, Smith CE, Nicolas F, Garaulet M. Differences in daily rhythms of wrist temperature between obese and normal-weight women: associations with metabolic syndrome features. Chronobiol Int. 2011 May;28(5):425-33. doi: 10.3109/07420528.2011.574766.

    PMID: 21721858BACKGROUND
  • Smith CE, Ordovas JM, Sanchez-Moreno C, Lee YC, Garaulet M. Apolipoprotein A-II polymorphism: relationships to behavioural and hormonal mediators of obesity. Int J Obes (Lond). 2012 Jan;36(1):130-6. doi: 10.1038/ijo.2011.24. Epub 2011 Mar 8.

    PMID: 21386805BACKGROUND
  • Sanchez-Moreno C, Ordovas JM, Smith CE, Baraza JC, Lee YC, Garaulet M. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J Nutr. 2011 Mar;141(3):380-5. doi: 10.3945/jn.110.130344. Epub 2011 Jan 5.

    PMID: 21209257BACKGROUND
  • Garaulet M, Corbalan-Tutau MD, Madrid JA, Baraza JC, Parnell LD, Lee YC, Ordovas JM. PERIOD2 variants are associated with abdominal obesity, psycho-behavioral factors, and attrition in the dietary treatment of obesity. J Am Diet Assoc. 2010 Jun;110(6):917-21. doi: 10.1016/j.jada.2010.03.017.

    PMID: 20497782BACKGROUND
  • Garaulet M, Corbalan MD, Madrid JA, Morales E, Baraza JC, Lee YC, Ordovas JM. CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int J Obes (Lond). 2010 Mar;34(3):516-23. doi: 10.1038/ijo.2009.255. Epub 2010 Jan 12.

    PMID: 20065968BACKGROUND
  • Garaulet M, Lee YC, Shen J, Parnell LD, Arnett DK, Tsai MY, Lai CQ, Ordovas JM. CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am J Clin Nutr. 2009 Dec;90(6):1466-75. doi: 10.3945/ajcn.2009.27536. Epub 2009 Oct 21.

    PMID: 19846548BACKGROUND
  • Gomez-Abellan P, Hernandez-Morante JJ, Lujan JA, Madrid JA, Garaulet M. Clock genes are implicated in the human metabolic syndrome. Int J Obes (Lond). 2008 Jan;32(1):121-8. doi: 10.1038/sj.ijo.0803689. Epub 2007 Jul 24.

    PMID: 17653067BACKGROUND
  • Lo MT, Bandin C, Yang HW, Scheer FAJL, Hu K, Garaulet M. CLOCK 3111T/C genetic variant influences the daily rhythm of autonomic nervous function: relevance to body weight control. Int J Obes (Lond). 2018 Feb;42(2):190-197. doi: 10.1038/ijo.2017.168. Epub 2017 Jul 24.

    PMID: 28736443BACKGROUND
  • Bonnet G, Gomez-Abellan P, Vera B, Sanchez-Romera JF, Hernandez-Martinez AM, Sookoian S, Pirola CJ, Garaulet M. Serotonin-transporter promoter polymorphism modulates the ability to control food intake: Effect on total weight loss. Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201700494. Epub 2017 Sep 1.

    PMID: 28766852BACKGROUND
  • Vera B, Dashti HS, Gomez-Abellan P, Hernandez-Martinez AM, Esteban A, Scheer FAJL, Saxena R, Garaulet M. Modifiable lifestyle behaviors, but not a genetic risk score, associate with metabolic syndrome in evening chronotypes. Sci Rep. 2018 Jan 17;8(1):945. doi: 10.1038/s41598-017-18268-z.

    PMID: 29343740BACKGROUND
  • Dashti HS, Gomez-Abellan P, Qian J, Esteban A, Morales E, Scheer FAJL, Garaulet M. Late eating is associated with cardiometabolic risk traits, obesogenic behaviors, and impaired weight loss. Am J Clin Nutr. 2021 Jan 4;113(1):154-161. doi: 10.1093/ajcn/nqaa264.

    PMID: 33022698BACKGROUND
  • Garaulet M, Vizmanos B, Muela T, Betancourt-Nunez A, Bonmati-Carrion MA, Vetter C, Dashti HS, Saxena R, Scheer FAJL. Evening types as determined by subjective and objective measures are more emotional eaters. Obesity (Silver Spring). 2023 May;31(5):1192-1203. doi: 10.1002/oby.23749.

    PMID: 37140408BACKGROUND
  • Vizmanos B, Cascales AI, Rodriguez-Martin M, Salmeron D, Morales E, Aragon-Alonso A, Scheer FAJL, Garaulet M. Lifestyle mediators of associations among siestas, obesity, and metabolic health. Obesity (Silver Spring). 2023 May;31(5):1227-1239. doi: 10.1002/oby.23765.

    PMID: 37140401BACKGROUND
  • De la Pena-Armada R, Longo-Silva G, Rodriguez-Martin M, Yang HW, Garaulet M. Key Determinants of Weight Loss Trajectory Across Different Periods of a Behavioral Weight Loss Intervention. Obesity (Silver Spring). 2026 Feb;34(2):357-371. doi: 10.1002/oby.70113. Epub 2026 Jan 20.

  • Rodriguez-Martin M, Szczerbinski L, Garaulet M, Dashti HS. The Effect of Habitual Sleep Duration on Weight Loss during a Behavioral Weight Loss Intervention in a Mediterranean Population. J Nutr. 2025 Nov;155(11):4060-4064. doi: 10.1016/j.tjnut.2025.09.010. Epub 2025 Sep 19.

  • Yang HW, De la Pena-Armada R, Sun H, Peng YQ, Lo MT, Scheer FAJL, Hu K, Garaulet M. Uncovering key factors in weight loss effectiveness through machine learning. Int J Obes (Lond). 2025 Jun;49(6):1189-1199. doi: 10.1038/s41366-025-01766-w. Epub 2025 May 6.

  • Dashti HS, Scheer FAJL, Saxena R, Garaulet M. Impact of polygenic score for BMI on weight loss effectiveness and genome-wide association analysis. Int J Obes (Lond). 2024 May;48(5):694-701. doi: 10.1038/s41366-024-01470-1. Epub 2024 Jan 24.

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, serum, saliva

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Marta Garaulet, PHD

    Universidad de Murcia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marta Garaulet, PHD

CONTACT

Purificacion Gomez-Abellan, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

June 10, 2016

First Posted

July 12, 2016

Study Start

January 1, 2008

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2032

Last Updated

May 6, 2026

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations